Orforglipron, an oral non-peptide GLP-1 drug, helps women with obesity or overweight lose significantly more weight than placebo, regardless of menopausal stage.

Misuse of the HINTS exam remains common. A new review clarifies which patients with acute dizziness should — and should not — ...

Patients with inflammatory myopathies experience pain patterns ranging from localized disease-related discomfort to ...

In hospitals, registered nurses (RNs) monitor patients during rounds, respond to call lights, and check vital signs. But ...

Women with extramammary Paget disease (EMPD) showed a lower risk for cancer-specific and all-cause mortality compared with ...

Patients with treatment-resistant depression who are persistently unable to feel pleasure have higher risks for suicidal ...

Intrauterine mepivacaine reduces pain during IUD placement, while 1 in 5 patients choose moderate intravenous sedation when ...

International consensus advises screening at three points during childhood for early-stage T1D, if the necessary ...

The findings highlight how subtle verbal and nonverbal behaviors may shape patient trust in reassuring medical information.

New genome analysis suggests the Kent MenB strain picked up DNA from harmless throat bacteria, raising its virulence.

The FDA has approved the once-weekly injectable basal insulin drug insulin efsitora alfa-gobe (Onswik, Eli Lilly) for use as ...

A clinician’s touch can detect things a lab test and AI dataset can’t and, practiced well, can put a patient at ease and earn ...